4592 — SanBio Co Income Statement
0.000.00%
Last trade - 00:00- ¥232bn
- ¥230bn
Annual income statement for SanBio Co, fiscal year end - January 31st, JPY millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5,802 | 6,602 | 7,899 | 4,291 | 3,507 |
| Operating Profit | -5,802 | -6,602 | -7,899 | -4,291 | -3,507 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3,211 | -4,560 | -4,697 | -2,542 | -3,011 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3,386 | -4,678 | -5,560 | -2,644 | -2,883 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3,386 | -4,678 | -5,560 | -2,644 | -2,883 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3,386 | -4,678 | -5,560 | -2,644 | -2,883 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -65.4 | -90.6 | -96 | -43.3 | -42 |
| Dividends per Share |